VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
VistaGen Therapeutics(US:VTGN) Businesswire·2026-01-17 04:42公司法律事件 - 投资者有机会牵头对Vistagen Therapeutics公司提起证券欺诈集体诉讼 [1] - 该诉讼由Schall Law Firm律所发起 [1]